MedTrace Logo

Effects of Myokinetic Stretching Technique With And Without Neural Flossing Technique In Lumbar Radiculopathy

NCT07628426 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-06-05

No results posted yet for this study

Summary

This single-blinded randomized clinical trial aims to evaluate the comparative effects of Myokinetic Stretching Technique (MST) alone versus MST combined with Neural Flossing Technique (NFT) in individuals with lumbar radiculopathy. A total of 22 participants aged 25-55 will be recruited through non-probability convenience sampling from rehabilitation clinics in Lahore and randomly assigned to two intervention groups

Conditions

  • Lumbar Radiculopathy

Interventions

OTHER

Myokinetic stretching

* Light aerobic activity (e.g., stationary cycling or brisk walking) to increase blood flow and prepare muscles for stretching• Myokinetic Stretching Technique (MST): - Target muscles: hamstrings, lumbar paraspinals, gluteals, hip flexors. - Involves both active (patient-initiated) and passive (therapist-assisted) stretches. * Sustained stretches held for 20-30 seconds with 3-5 repetitions. * Focus on length-tension balance, postural correction, and neuromuscular re- education. Progressive loading as tolerated

OTHER

nyokinetic stretching with neural flossing technique

* Myokinetic stretching with Neural Flossing Technique (NFT): - * Target: sciatic nerve and related neural structures. - * Performed as oscillatory, controlled gliding movements ("sliders" and "tensioners"). * Techniques include supine straight leg raise with ankle dorsiflexion and cervical flexion/extension. - 3 sets of 10-15 repetitions, increasing intensity and duration based on tolerance. Aims to reduce neural tension and improve neurodynamic mobility.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Anam Iqbal, DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-06
Primary Completion
2026-08-05
Completion
2026-09-06

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07628426 on ClinicalTrials.gov